These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35255784)

  • 1. New Advances of CRISPR/Cas9 Technique and its Application in Disease Treatment and Medicinal Plants Research.
    Wan HF; Han WJ; Zhou L; Wang S; Sui C
    Curr Pharm Biotechnol; 2022; 23(14):1678-1690. PubMed ID: 35255784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
    Dey A; Nandy S
    Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospecting application of CRISPR/Cas9 genome editing technology in research of medicinal plants].
    Hu TY; Gao W; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):2953-2957. PubMed ID: 28920331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
    Zhang D; Zhang Z; Unver T; Zhang B
    J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Application of CRISPR/Cas9 System to Engineer Abiotic Stress Tolerance in Plants.
    Ahmed T; Noman M; Shahid M; Muhammad S; Tahir Ul Qamar M; Ali MA; Maqsood A; Hafeez R; Ogunyemi SO; Li B
    Protein Pept Lett; 2021; 28(8):861-877. PubMed ID: 33602066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glance at genome editing with CRISPR-Cas9 technology.
    Barman A; Deb B; Chakraborty S
    Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of CRISPR/Cas9 technology for modification of the plant genome.
    Deb S; Choudhury A; Kharbyngar B; Satyawada RR
    Genetica; 2022 Feb; 150(1):1-12. PubMed ID: 35018532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
    Amritha PP; Shah JM
    Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRISPR/Cas9 system and its applications in crop genome editing.
    Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
    Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
    Pei WD; Zhang Y; Yin TL; Yu Y
    Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review.
    Sherkatghanad Z; Abdar M; Charlier J; Makarenkov V
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37080758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
    Wada N; Ueta R; Osakabe Y; Osakabe K
    BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.
    Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y
    Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing using CRISPR/Cas9-targeted mutagenesis: An opportunity for yield improvements of crop plants grown under environmental stresses.
    Abdelrahman M; Al-Sadi AM; Pour-Aboughadareh A; Burritt DJ; Tran LP
    Plant Physiol Biochem; 2018 Oct; 131():31-36. PubMed ID: 29628199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing by CRISPR/Cas9 in the obligatory outcrossing Medicago sativa.
    Gao R; Feyissa BA; Croft M; Hannoufa A
    Planta; 2018 Apr; 247(4):1043-1050. PubMed ID: 29492697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.